Back to beauty: Former Allergan chief Saunders scoops up aesthetics company in $1.1B deal
In a return to the beauty business, former Allergan CEO Brent Saunders sealed a $1.1 billion deal for a hot and trendy med spa facial...
Allergan
AbbVie pegs growth to booming Skyrizi, Rinvoq in post-merger future. But neurology could be a ‘sleeper’
With its $63 billion merger with Allergan in the rearview, the new AbbVie is facing a major challenge as U.S. biosimilars for Humira cast a...
Ironwood, AbbVie add ‘bloating’ and ‘discomfort’ to Linzess label to reach more IBS-C patients
Ironwood and AbbVie can now add “bloating” and “discomfort” to marketing for irritable bowel syndrome with constipation (IBS-C) drug Linzess, thanks to a supplemental NDA approval...